Sunday, May 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Probenecid shows activity against respiratory syncytial virus

by Medical Finance
in Coronavirus
Study: Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Image Credit:  Iren_Geo/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Among the most common viruses causing viral respiratory disease is the respiratory syncytial virus (RSV), with the greatest burden of disease in infants and young children.

Many researchers have tried to reduce this burden via RSV vaccines and antivirals. Now, a new study, published online in the journal Viruses, describes the antiviral activity of the approved drug probenecid against this virus.

Study: Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Image Credit:  Iren_Geo/Shutterstock
Study: Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Image Credit: Iren_Geo/Shutterstock

Introduction

RSV causes over 150,000 hospitalizations among children each year, and hundreds of millions of dollars are spent on healthcare expenditures due to this pathogen.

At present, only ribavirin and palivizumab are known to have any activity against RSV, that too with mixed results. In fact, the emergence of resistance mutations to the latter, which has to be given monthly by injection to high-risk infants throughout the RSV season, will reduce its efficacy considerably from the current 50% decrease in RSV-related infant hospitalizations.

Repurposing is an accepted approach whereby already approved drugs are successfully shown to be effective for another indication, cutting down on drug development costs and the timeline for approval and marketing. One way is to examine the pathways whereby viruses interact with their hosts, so as to identify druggable targets.

For instance, finding a host cell protein that is required for viral replication could help identify a drug that targets that protein.

This could help find an antiviral that acts against multiple viruses via a common pathway. In the current paper, the researchers performed high-throughput screening (HTS) along with RNA interference (RNAi), in order to silence specific host genes and thus find out which of the host genes and cellular pathways are important as druggable antiviral targets.

The current study builds on earlier work by the same team to find genes of potential importance in the inhibition of influenza A virus (IAV) replication. Here, they had found that organic anion transporter-3 (OAT3) gene is essential in this process, and that the OAT3 or SLC22A8 gene is inhibited by the approved uricosuric drug probenecid.

In this way, probenecid was able to drastically reduce the replication of IAV in cell cultures and in mice. The SLC gene family is common to humans and mice. When cells in culture were induced to express siRNA that targeted the OAT3 gene, IAV replication stopped. The specificity of this action was indicated by the inability of OAT1, OAT2, OAT4 and OAT7 inhibitors to achieve the same result.

Probenecid is both involved in uric acid excretion in urine and in OAT3 inhibition, and is used widely for the treatment of gout. It is well tolerated and has few adverse effects, but may have other effects on the inflammatory system via its action on other ion channels. The fact that it does not target RNA-dependent RNA polymerase attracted the attention of the current team of scientists.

Findings

The use of probenecid in three different cell lines and in mice showed a marked drop in RSV replication, as expected from earlier studies involving influenza virus and the currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). No toxicity was evident.

The drug had equivalent efficacy against RSV A and RSV B. The same results were observed with RSV-infected mice, with a significant reduction in virus load. This was mediated via a reduction in OAT3 expression. When pretreated with probenecid, cells became resistant to RSV replication, with the half-maximal inhibitory concentration (IC50) against RSV A2 being <0.1 uM, and against RSV B1 0.85 uM.

In other words, this drug affected RSV replication at nanomolar concentrations, which is very much lower than the concentration required to inhibit IAV replication. Both pre-treatment and post-exposure administration of probenecid showed the ability to reduce lung viral titers, corresponding to the prophylactic and therapeutic utility of this drug in RSV infection.

Implications

According to the researchers,

The studies showed that nanomolar concentrations of all probenecid regimens prevent RSV strain A and B replication in vitro and RSV strain A in vivo, representing a potential prophylactic and chemotherapeutic for RSV.”

Such data points to the need to explore the use of probenecid to prevent RSV infection in children aged 2-14 years, who have been tested for safety when administered this drug along with antibiotics. Further studies will be required to establish its efficacy in vivo, and using other RSV strains.

The required dosing protocols and duration of treatment and the further effects of the drug on communication between cells and on the inflammatory cascade, attributable to the role of probenecid on pannexin 1 channels, need to be elucidated.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response. Image Credit: Kateryna Kon/Shutterstock

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

by Medical Finance
May 29, 2022
0

Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have emerged since the coronavirus disease 2019 (COVID-19) pandemic. These...

Study: Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function. Image Credit: Naeblys/Shutterstock

Impact of clustered mutations in SARS-CoV-2 Omicron spike function

by Medical Finance
May 29, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers explored the characteristics of severe acute respiratory syndrome coronavirus...

Study: The impact of recurrent rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2. Image Credit: Cryptographer/Shutterstock

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

by Medical Finance
May 29, 2022
0

Lateral flow devices, or lateral flow tests, have played a significant role in helping to identify infectious individuals during the...

Study: Obesity associated with attenuated tissue immune cell responses in COVID-19. Image Credit: Eve Orea/Shutterstock

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

by Medical Finance
May 29, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers analyzed the lung and peripheral blood immune responses associated with...

Study: Booster vaccination to curtail COVID-19 resurgence - population-level implications of the Israeli campaign. Image Credit: Corona Borealis Studio/Shutterstock

Impact of SARS-CoV-2 booster vaccination on Delta variant resurgence in Israel

by Medical Finance
May 29, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers explored the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Study: “Never let a good crisis go to waste”: Positives from disrupted maternity care in Australia during COVID-19. Image Credit: Prostock-studio/Shutterstock

Positive effects of altered maternal care during COVID-19 in Australia

by Medical Finance
May 29, 2022
0

In a recent study published in Midwifery, researchers reported on the positive outcomes of the coronavirus disease 2019 (COVID-19) pandemic...

Next Post
Dog brains can detect speech and show different activity patterns to many languages

Study finds more than 1,000 gene-activation differences between female and male mouse brains

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

Optical imaging reveals how cancer cells hijack metabolic activity to fuel pancreatic tumor growth

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Impact of COVID-19 symptoms on social aspects of life among female long haulers: A qualitative study. Image Credit: Dragana Gordic/Shutterstock
    Study explores the social impact of COVID-19 symptoms among female long haulers
  • Study: Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function. Image Credit: Naeblys/Shutterstock
    Impact of clustered mutations in SARS-CoV-2 Omicron spike function
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply